Profile data is unavailable for this security.
About the company
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. It develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm, and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. It provides devices directly to patients and bill their insurance companies directly. It also sells its products through various other sales channels, including through orthotics and prosthetics providers, the veteran’s administration, and others.
- Revenue in USD (TTM)25.24m
- Net income in USD-8.38m
- Incorporated2004
- Employees101.00
- LocationMyomo Inc137 Portland Street, 4Th FloorBOSTON 02114United StatesUSA
- Phone+1 (617) 996-9058
- Fax+1 (302) 655-5049
- Websitehttps://myomo.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sensus Healthcare Inc | 36.37m | 6.65m | 110.95m | 35.00 | 16.63 | 2.10 | 16.16 | 3.05 | 0.4072 | 0.4072 | 2.23 | 3.23 | 0.6601 | 1.10 | 2.65 | 1,039,057.00 | 12.06 | 10.29 | 13.25 | 12.14 | 60.23 | 62.85 | 18.27 | 15.29 | 8.20 | -- | 0.00 | -- | -45.20 | -1.58 | -98.00 | -- | -23.16 | -- |
| Harvard Bioscience, Inc. | 101.13m | -10.68m | 112.08m | 391.00 | -- | 1.67 | -- | 1.11 | -0.2471 | -0.2471 | 2.35 | 1.54 | 0.7441 | 1.64 | 6.88 | 258,631.70 | -7.86 | -3.29 | -9.44 | -3.89 | 58.39 | 56.67 | -10.56 | -4.57 | 0.9416 | -1.31 | 0.3467 | -- | -0.9573 | -1.45 | 64.11 | -- | 18.10 | -- |
| TELA Bio Inc | 64.74m | -42.11m | 112.78m | 227.00 | -- | 26.44 | -- | 1.74 | -1.71 | -1.71 | 2.64 | 0.1163 | 0.8376 | 1.48 | 7.62 | 285,215.80 | -54.48 | -52.00 | -66.54 | -60.95 | 68.61 | 65.32 | -65.04 | -107.65 | 2.52 | -8.69 | 0.9343 | -- | 41.13 | 47.85 | -5.35 | -- | -17.12 | -- |
| 908 Devices Inc. | 52.69m | -37.99m | 123.72m | 230.00 | -- | 0.7907 | -- | 2.35 | -1.15 | -1.15 | 1.60 | 4.52 | 0.2511 | 1.54 | 4.95 | 229,069.60 | -18.11 | -14.16 | -20.12 | -15.35 | 52.32 | 53.02 | -72.10 | -64.25 | 4.23 | -- | 0.00 | -- | 7.21 | 17.89 | -8.45 | -- | 22.98 | -- |
| KORU Medical Systems Inc | 30.82m | -11.76m | 131.60m | 82.00 | -- | 7.03 | -- | 4.27 | -0.2574 | -0.2574 | 0.6742 | 0.4082 | 0.9737 | 2.94 | 6.50 | 375,817.30 | -37.15 | -17.60 | -43.48 | -20.29 | 62.49 | 59.44 | -38.16 | -21.70 | 3.27 | -- | 0.0195 | -- | 2.23 | 10.44 | -58.65 | -- | 11.10 | -- |
| Pro-Dex Inc | 56.80m | 5.21m | 139.11m | 148.00 | 27.89 | 4.56 | 21.78 | 2.45 | 1.53 | 1.53 | 16.34 | 9.36 | 1.09 | 2.48 | 4.64 | 383,770.30 | 10.03 | 12.33 | 12.35 | 15.30 | 28.25 | 31.26 | 9.17 | 12.13 | 1.94 | 5.31 | 0.304 | 0.00 | 16.83 | 14.66 | -69.93 | -12.47 | -6.80 | -- |
| Myomo Inc | 25.24m | -8.38m | 145.39m | 101.00 | -- | 15.66 | -- | 5.76 | -0.2294 | -0.2294 | 0.6847 | 0.3072 | 1.51 | 3.11 | 8.08 | 249,892.40 | -50.25 | -81.78 | -81.40 | -115.27 | 70.03 | 68.50 | -33.22 | -85.76 | 1.62 | -- | 0.00 | -- | 23.70 | 51.09 | 24.00 | -- | 2.82 | -- |
| Acme United Corp | 190.49m | 19.52m | 153.38m | 645.00 | 8.41 | 1.44 | 7.11 | 0.8052 | 4.94 | 4.94 | 46.90 | 28.77 | 1.18 | 2.09 | 5.84 | 295,331.70 | 12.13 | 7.09 | 14.25 | 8.29 | 39.37 | 35.72 | 10.25 | 5.50 | 1.91 | 7.06 | 0.2337 | 18.81 | -1.27 | 6.88 | 486.31 | 31.08 | 9.02 | 4.84 |
| EUDA Health Holdings Ltd | 3.81m | -17.99m | 154.21m | 106.00 | -- | -- | -- | 40.46 | -0.4821 | -0.4451 | 0.1487 | -0.1685 | 1.86 | -- | 7.21 | 35,957.55 | -876.41 | -- | -- | -- | 22.05 | -- | -472.08 | -- | -- | -43.68 | -- | -- | -1.54 | -- | 66.17 | -- | -- | -- |
| Cibus Inc | 2.96m | -291.86m | 155.18m | 183.00 | -- | 0.4488 | -- | 52.41 | -16.39 | -16.39 | 0.1545 | 11.75 | 0.0043 | -- | 3.09 | 16,180.33 | -53.70 | -86.28 | -64.26 | -96.45 | -- | -- | -12,400.74 | -792.07 | -- | -2.66 | 0.0032 | -- | 1,057.33 | 50.41 | -1,484.44 | -- | 18.53 | -- |
| Akoya Biosciences Inc | 93.22m | -60.35m | 156.91m | 330.00 | -- | 7.05 | -- | 1.68 | -1.22 | -1.22 | 1.89 | 0.4498 | 0.5605 | 1.93 | 6.34 | 282,472.70 | -36.29 | -- | -45.98 | -- | 57.57 | -- | -64.74 | -- | 1.98 | -8.00 | 0.7755 | -- | 29.09 | -- | 10.36 | -- | -- | -- |
| Stereotaxis Inc | 23.75m | -22.08m | 158.31m | 122.00 | -- | 13.67 | -- | 6.67 | -0.265 | -0.265 | 0.285 | 0.202 | 0.5632 | 1.14 | 5.04 | 194,639.30 | -49.21 | -25.02 | -71.93 | -34.12 | 59.28 | 67.57 | -87.38 | -41.90 | 1.53 | -- | 0.00 | -- | -4.89 | -1.82 | -12.33 | -- | 6.63 | -- |
| InfuSystem Holdings Inc | 129.37m | 366.00k | 166.47m | 499.00 | 498.72 | 3.11 | 13.29 | 1.29 | 0.0157 | 0.0157 | 5.99 | 2.51 | 1.22 | 10.38 | 6.44 | 259,264.50 | 0.3465 | 4.60 | 0.401 | 5.69 | 49.68 | 56.43 | 0.2829 | 4.07 | 1.64 | 1.97 | 0.3898 | 0.00 | 14.44 | 13.38 | 4,744.44 | -- | 6.01 | -- |
| Senseonics Holdings Inc | 24.04m | -80.46m | 182.83m | 132.00 | -- | 285.70 | -- | 7.61 | -0.1323 | -0.1323 | 0.0395 | 0.0714 | 0.1815 | 2.58 | 5.99 | 182,113.60 | -60.74 | -73.65 | -74.52 | -106.97 | 12.04 | -40.41 | -334.69 | -649.86 | 2.89 | -10.93 | 0.5802 | -- | 36.62 | 3.43 | -142.49 | -- | -18.76 | -- |
| Nevro Corp | 426.10m | -77.44m | 189.40m | 1.22k | -- | 0.6891 | -- | 0.4445 | -2.12 | -2.12 | 11.69 | 7.37 | 0.7266 | 1.11 | 5.93 | 350,697.90 | -13.21 | -13.64 | -15.59 | -16.68 | 68.06 | 68.54 | -18.18 | -20.67 | 3.53 | -28.95 | 0.4433 | -- | 4.63 | 1.88 | -3,172.74 | -- | 0.9012 | -- |
Data as of Nov 09 2024. Currency figures normalised to Myomo Inc's reporting currency: US Dollar USD
48.04%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Rosalind Advisors, Inc.as of 30 Sep 2024 | 3.02m | 10.00% |
| AIGH Capital Management LLCas of 30 Jun 2024 | 2.92m | 9.65% |
| Herr Investment Group LLCas of 30 Jun 2024 | 2.85m | 9.42% |
| Triple Gate Capital LPas of 04 Jun 2024 | 2.83m | 9.35% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 1.20m | 3.95% |
| Essex Investment Management Co. LLCas of 30 Sep 2024 | 899.14k | 2.98% |
| Legato Capital Management LLCas of 30 Sep 2024 | 307.27k | 1.02% |
| Geode Capital Management LLCas of 30 Jun 2024 | 232.38k | 0.77% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 139.92k | 0.46% |
| Renaissance Technologies LLCas of 30 Jun 2024 | 135.08k | 0.45% |
More ▼
Data from 04 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
